+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5212221
  • Report
  • November 2020
  • Region: Global
  • 229 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Captis Biotechnology Inc
  • Fahy Gurteen UK Ltd
  • Laboratorios SALVAT SA
  • Oncology Venture U.S. Inc
  • Stage I Diagnostics Inc
  • MORE
Summary

The publisher's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ovarian Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ovarian Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ovarian Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 2cureX AB
  • Captis Biotechnology Inc
  • Fahy Gurteen UK Ltd
  • Laboratorios SALVAT SA
  • Oncology Venture U.S. Inc
  • Stage I Diagnostics Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Ovarian Cancer Diagnostic Tests Overview

3 Products under Development
3.1 Ovarian Cancer - Pipeline Products by Stage of Development
3.2 Ovarian Cancer - Pipeline Products by Territory
3.3 Ovarian Cancer - Pipeline Products by Regulatory Path
3.4 Ovarian Cancer - Pipeline Products by Estimated Approval Date
3.5 Ovarian Cancer - Ongoing Clinical Trials

4 Ovarian Cancer - Pipeline Products under Development by Companies
4.1 Ovarian Cancer Companies - Pipeline Products by Stage of Development
4.2 Ovarian Cancer - Pipeline Products by Stage of Development

5 Ovarian Cancer Companies and Product Overview

6 Ovarian Cancer- Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Ovarian Cancer - Pipeline Products by Stage of Development
Table 2: Ovarian Cancer - Pipeline Products by Territory
Table 3: Ovarian Cancer - Pipeline Products by Regulatory Path
Table 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
Table 5: Ovarian Cancer - Ongoing Clinical Trials
Table 6: Ovarian Cancer Companies - Pipeline Products by Stage of Development
Table 7: Ovarian Cancer - Pipeline Products by Stage of Development
Table 8: 2cureX AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: IndiTreat - OVA - Product Status
Table 10: IndiTreat - OVA - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Companion Diagnostic Test - Ovarian Cancer - Product Status
Table 13: Companion Diagnostic Test - Ovarian Cancer - Product Description
Table 14: AB ANALITICA srl Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Predictive Biomarker Kit - Ovarian Cancer - Product Status
Table 16: Predictive Biomarker Kit - Ovarian Cancer - Product Description
Table 17: Accudava Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: SEPEX - Product Status
Table 19: SEPEX - Product Description
Table 20: SETAX - Product Status
Table 21: SETAX - Product Description
Table 22: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 23: ImmunoSEQ Dx - Ovarian Cancer - Product Status
Table 24: ImmunoSEQ Dx - Ovarian Cancer - Product Description
Table 25: Almac Diagnostic Services Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 26: ALM AADx Assay - Product Status
Table 27: ALM AADx Assay - Product Description
Table 28: Diagnostic Test - Ovarian Cancer - Product Status
Table 29: Diagnostic Test - Ovarian Cancer - Product Description
Table 30: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status
Table 31: DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description
Table 32: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Multiplex Ovarian Cancer Biomarker Assay - Product Status
Table 34: Multiplex Ovarian Cancer Biomarker Assay - Product Description
Table 35: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Cchek - Ovarian Cancer Confirmatory Test - Product Status
Table 37: Cchek - Ovarian Cancer Confirmatory Test - Product Description
Table 38: Cchek - Ovarian Cancer Recurrence Test - Product Status
Table 39: Cchek - Ovarian Cancer Recurrence Test - Product Description
Table 40: Cchek - Ovarian Cancer Screening Test - Product Status
Table 41: Cchek - Ovarian Cancer Screening Test - Product Description
Table 42: Cchek - Ovarian Cancer Treatment Monitoring Test - Product Status
Table 43: Cchek - Ovarian Cancer Treatment Monitoring Test - Product Description
Table 44: Anixa Diagnostics Corporation - Ongoing Clinical Trials Overview
Table 45: Cchek - Ovarian Cancer Screening Test - The Coupling of MDSCs with a Computational Analytic Method to Detect Solid Tumors
Table 46: AroCell AB Pipeline Products & Ongoing Clinical Trials Overview
Table 47: TK 210 Assay - Ovarian Cancer - Product Status
Table 48: TK 210 Assay - Ovarian Cancer - Product Description
Table 49: Arrayit Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Finger Stick Test - Ovarian Cancer - Product Status
Table 51: Finger Stick Test - Ovarian Cancer - Product Description
Table 52: Aspira Labs Pipeline Products & Ongoing Clinical Trials Overview
Table 53: OVA1 Plus Test - Product Status

List of Figures
Figure 1: Ovarian Cancer - Pipeline Products by Stage of Development
Figure 2: Ovarian Cancer - Pipeline Products by Territory
Figure 3: Ovarian Cancer - Pipeline Products by Regulatory Path
Figure 4: Ovarian Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Ovarian Cancer - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • 2cureX AB
  • A&G Pharmaceutical Inc
  • AB ANALITICA srl
  • Accudava Inc
  • Adaptive Biotechnologies Corp
  • Almac Diagnostic Services Ltd
  • Angle Biosciences Inc
  • Anixa Diagnostics Corporation
  • AroCell AB
  • Arrayit Corporation
  • Aspira Labs
  • Aurelium BioPharma Inc.
  • Avant Diagnostics Inc
  • Ayanda Biosystems SA (Inactive)
  • BARD1 Life Sciences Ltd
  • Becton Dickinson and Co
  • BioFluidica Microtechnologies LLC
  • Bioindustry Park Silvano Fumero SpA
  • Brigham and Women's Hospital
  • Captis Biotechnology Inc
  • Celcuity Inc
  • Celula Inc
  • Ceres Nanosciences Inc
  • Chronix Biomedical Inc
  • Clarient Inc
  • ClavGen Therapeutics LLC
  • Cleveland Diagnostics Inc.
  • Courtagen Life Sciences Inc
  • Dana-Farber Cancer Institute Inc
  • Diazyme Laboratories Inc
  • Entopsis LLC
  • Eventus Diagnostics Inc (Inactive)
  • Exact Sciences Corp
  • Exiqon AS
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • French National Institute of Health and Medical Research
  • Ganymed Pharmaceuticals AG
  • Georgia Institute of Technology
  • Gina-Life Diagnostics Ltd
  • GlycoZym USA Inc
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • HealthTell Inc
  • Hide and Seq
  • Hudson Institute of Medical Research
  • Ikonisys Inc
  • INEX Innovate Pte Ltd
  • InterGenetics Inc
  • InterVenn BioSciences
  • Johns Hopkins University
  • KIYATEC Inc
  • Lab Discoveries Ltd
  • Laboratorios SALVAT SA
  • Louisville Bioscience Inc (Inactive)
  • MabCure Inc
  • Massachusetts Institute of Technology
  • MDNA Life Sciences Inc
  • Metabolon Inc
  • Milagen Inc
  • MyCartis NV
  • Nagoya University
  • Nanostics Inc
  • Novel Bio-spectrum Technologies Inc (Inactive)
  • Olink Proteomics AB
  • Olympia Diagnostics Inc
  • Oncgnostics GmbH
  • Oncimmune (USA) LLC
  • Oncology Venture U.S. Inc
  • Orion Genomics LLC
  • OTraces Inc
  • Peregrine Pharmaceuticals, Inc.
  • Peri Rx Inc
  • Precision Biologics Inc
  • Preora Healthcare Inc
  • Princess Margaret Cancer Centre
  • Protagen AG
  • Proteomika (Inactive)
  • Provista Diagnostics Inc
  • Queen's University Belfast
  • Rosetta Genomics Ltd
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • SomaLogic Inc
  • Soricimed Biopharma Inc
  • Stage I Diagnostics Inc
  • StageZero Life Sciences Ltd
  • SurExam Life Science & Technology Co.
  • Taizhou ZECEN Biotech Co Ltd
  • Target Discovery Inc
  • Teva Pharmaceutical Industries Ltd
  • The University of Manchester
  • Tradewind BioScience Inc
  • Treos Bio Inc
  • University of Adelaide
  • University of Arkansas for Medical Sciences
  • University of California San Diego
  • University of Chicago
  • University of Montreal
  • University of Pittsburgh
  • University of South Florida
  • University of Texas MD Anderson Cancer Center
  • US Biomarkers Inc
  • Vermillion Inc
  • Vitruvian Biomedical Inc
  • Wistar Institute
  • Yale University
  • ZORA Biosciences Oy
Note: Product cover images may vary from those shown
Adroll
adroll